BBIO vs EIX
BridgeBio Pharma Inc (BBIO) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
BBIO currently screens at market cap $13.24B. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the BBIO and EIX stock pages for the full models.
Not investment advice.